📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation. (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/ejp.983

PubMed Identifier: 28107590

Publication URI: http://europepmc.org/abstract/MED/28107590

Type: Journal Article/Review

Volume: 21

Parent Publication: European journal of pain (London, England)

Issue: 5

ISSN: 1090-3801